Adam McArthur
Senior counsel, strategic partnering and business development
AstraZeneca
Adam McArthur has ten years’ experience at two of the world’s most prominent pharmaceuticals companies:Novartis and now AstraZeneca. He is part of a 22-strong legal team responsible for global business development activities in respiratory, inflammation and ophthalmology.
Work includes all aspects of IP exploitation, licensing deals, spin-outs, research collaborations, M&As, and product divestments. One of McArthur’s recent work highlights is the 2011 sale of Astra Tech, to Dentsply for $1.8bn. McArthur led the team, advised by Paul Maher of Greenberg Traurig Maher in London.
Law firms used: Covington & Burling, Davis Polk & Wardwell, Freshfields Bruckhaus Deringer, Greenberg Traurig Maher
2007-present: Senior counsel, strategic partnering and business development, AstraZeneca
2005-07: Legal counsel, Novartis
2003-05: Associate, Wragge & Co